ARTCLINE GmbH

About ARTCLINE GmbH

ARTCLINE develops innovative therapeutic procedures for intensive care medicine.

Products & Services

Therapeutic Procedures for Intensive Care:Innovative solutions focused on intensive care medicine, with details on technology and products available.

Specialties

Intensive Care Medicine Bio-Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Capital Increase T: - FT: Equity Capital Increase	A: 4400000 MR: - FA: EUR 4.4 million FAN: 4400000	D: 2024-03-25 FD: 2024-03-25	3 investors
2	RT: Equity Financing T: - FT: Equity Financing	A: 4752000 MR: - FA: EUR 4.4 million FAN: 4752000	D: 2024-03-25 FD: 2024-03-25	3 investors

Equity Capital Increase Latest

2024-03-25

$4.4M

3 investors (Pro only)

Equity Financing 2024-03-25

$4.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jens Altrichter

Managing Director & Founder

D

Dirk Hessel

Managing Director

S

Steffen Mitzner

CSO & founder

J

John Peitschner

CFO

J

Jan Stange

Physician

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

ARTCLINE GmbH Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised